ArticleCureus2025
Comparison of Conventional Therapies With Stem Cell Therapy in the Treatment of Heart Disease.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHeart disease remains a leading cause of mortality and morbidity worldwide. Conventional treatment options, including pharmacological therapies and surgical interventions, have been effective in managing symptoms and preventing further progression of the disease.
objectiveThis study aims to compare the efficacy and safety of stem cell therapy with conventional therapies in patients with heart disease.
methodsThis prospective cohort study was conducted at Nottingham University Hospital, NHS, UK, from January 2024 to December 2024. A total of 95 patients were added to the study. Patients were divided into two groups: 47 patients received stem cell therapy, and 48 patients received conventional therapy, which included pharmacological treatments, surgical procedures, or implantable devices. The primary outcomes assessed were improvement in left ventricular ejection fraction (LVEF), exercise capacity measured by the six-minute walk test, and quality of life using the Minnesota Living with Heart Failure Questionnaire (MLHFQ).
resultsThe stem cell therapy group showed significant improvements in left ventricular ejection fraction (LVEF), increasing from 30.2% ± 8.4% at baseline to 43.6% ± 9.7% after six months (p < 0.01). In contrast, the conventional therapy group showed a smaller increase in LVEF, from 32.5% ± 7.9% to 36.8% ± 8.1% (p = 0.04). Exercise capacity, measured by the six-minute walk test, improved by 80 meters in the stem cell group compared to a 30-meter improvement in the conventional group (p < 0.001). Quality of life, assessed using the MLHFQ, improved significantly more in the stem cell group, with a reduction in score from 56.2 ± 15.3 to 38.5 ± 12.1 (p < 0.001), versus a reduction from 54.7 ± 14.5 to 48.6 ± 13.2 (p = 0.02) in the conventional therapy group. Hospitalization rates were lower in the stem cell group (10.6%) compared to the conventional group (27.1%) (p = 0.03).
conclusionsIt is concluded that stem cell therapy offers significant advantages over conventional therapies in the management of heart disease, particularly in terms of improving cardiac function, exercise capacity, and quality of life. Unlike previous studies that evaluated stem cell therapy in isolation or without direct comparison, this article uniquely provides a head-to-head analysis against conventional treatments in a prospective cohort, offering practical insights into how stem cell therapy may complement or outperform current standards of care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.